This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813434 | PMC |
| http://dx.doi.org/10.7573/dic.2020-12-1 | DOI Listing |
Publication Analysis
Top Keywords
connective tissue
8
tissue disease-related
8
disease-related interstitial
8
interstitial lung
8
lung disease
8
special issue
8
current therapeutic
4
therapeutic strategies
4
strategies connective
4
disease introduction
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!